Old age psychiatry

Published on 23/05/2015 by admin

Filed under Psychiatry

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2048 times

CHAPTER 17 Old age psychiatry

The world is ageing. Population ageing leads to more people being affected by disorders whose prevalence rises with age, such as dementia. The proportion of Australians aged 65 and over is expected to double from 13% to 27% of the total population between 2006 and 2051. Past high birth and immigration rates, which have fallen dramatically since the 1970s, are the main reasons for this demographic change. Older people form a smaller proportion of the population in developing countries, but their numbers are growing quickly. The median age of people in China will rise from 30 to 45 years by 2050, when over a third will be aged above 60.

Although most elderly Australians are well and have a good quality of life, it is not unusual for very old people to be widowed, to live alone and to have health problems that limit independence. Over half enter residential care eventually.

The specialty of old age psychiatry offers assessment and treatment to older people with mental disorders. Old age psychiatry is a multidisciplinary specialty and requires teamwork. All doctors need to display patience and compassion, especially when dealing with the old and frail.

Dementia

Dementia is an acquired decline in higher mental functioning (especially memory, intellect and personality) occurring in an alert patient (to distinguish it from delirium) that affects multiple cognitive functions (not just memory) and interferes significantly with everyday function. Most dementias are irreversible and progressive.

Currently, over 27 million people worldwide are affected by dementia, and this number is projected to double every 20 years, surpassing 100 million by 2050. After age 60, the prevalence rate of dementia doubles every 5 years, rising from 1% at age 65 to 25% at age 85 (see Box 17.1 for the main causes of dementia in Australia). Most new cases will appear in developing countries. However, Australia will experience a big rise from 200,000 (1% of the population) in 2006 to 730,000 (2.8%) by 2051. In 2005, 25,000 Australians were newly diagnosed as having dementia, but, by 2050, 175,000 new cases will arise annually.

Assessment of the person with suspected dementia

Management

Medical issues

Tasks include establishing a diagnosis of dementia and its most likely aetiology, excluding treatable causes including depression and delirium as sole or contributing precipitants of confusion, and ensuring optimal physical health. The latter is important because patients with dementia often forget to mention symptoms, fail to attend appointments for investigations, and do not take medications reliably. Incidental physical pathology is common, so doctors should look for it. Attention should be paid to the effects of the dementia or other mental disorder on the family member(s) who care(s) for the affected person. Many carers are anxious, depressed or grieving, and may experience ‘carer burnout’.

Cholinesterase inhibitors (donepezil, galantamine and rivastigmine) can improve the cognitive symptoms of Alzheimer’s disease and slow its progression a little. Some treated patients become more alert and function better, but not all patients benefit. However, some patients worsen notably when medication is stopped, even in later stages. Cholinesterase inhibitors can cause nausea, vomiting, diarrhoea, vivid dreams and muscle cramps, but most patients do not develop these side effects if the dose is titrated up slowly. Memantine, an N-methyl-D-aspartate (NMDA) receptor blocker, may be of modest benefit when patients cannot tolerate or fail to benefit from a cholinesterase inhibitor.

Psychotropic drugs have a limited role in dementia management. Antipsychotic medications are used when delusions, hallucinations, misidentifications or aggression distress the patient or others. Evidence for efficacy is limited. Risperidone (up to 2 mg daily) is the drug of choice because it has been tested most thoroughly in this population, but it (and other antipsychotics) may raise the risk of stroke and should be avoided in patients with poorly controlled atrial fibrillation, hypertension, diabetes mellitus or previous stroke. If prescribed, drugs must be reviewed regularly, tapered and then ceased when the symptoms that prompted the prescription have remitted.

Antidepressants can treat comorbid major depression. Selective serotonin reuptake inhibitors (SSRIs) are the drugs of first choice.

Personal and family issues

People with mild dementia can express preferences about future care, assign enduring power of attorney and sometimes can make a will. The diagnosis should be explained with sensitivity and hope, given the availability of medications and excellent support services.

Assessment of activities of daily living is important. Are there difficulties with dressing, washing, toileting and bathing, or with cooking, housekeeping, shopping and handling money? How much help is needed and who gives it? What services are in place? Are relatives distressed by challenging or dangerous behaviours?

A diagnosis should be accompanied by advice to carers about strategies to minimise conflict. Argumentative patients should be humoured rather than challenged. Those who resist dressing or bathing should not be forced to conform to a timetable. Distraction, music and touch sometimes help. Carers need to ventilate concerns and have chances to rest. Home help, meals on wheels, day care, respite care, dosette boxes to organise medications, help with bathing and carer support groups may sometimes be helpful. Patients and carers should be referred to Alzheimer’s Australia for education, advice and carer support. Carers experience high rates of depression, anxiety, distress, isolation, physical ill health and financial hardship. These problems can be diminished by education, advice and support, and by treating any manifest psychiatric disorder.

Admission to a residential facility comes sooner for those who live alone or whose carer is frail, but a move from familiar surroundings can worsen confusion. Any shift should be carefully planned.

Delirium

Delirium is characterised by acute onset of fluctuating cognitive impairment and diminished attention. It affects at least 20% of patients aged over 65 who enter a general hospital. It is often unrecognised. If a proper history is taken, a story of recent abrupt cognitive decline with a fluctuating mental state over hours or days will emerge.

Prevention strategies should focus on orientation, early mobilisation, minimising the use of psychotropic drugs, preventing sleep deprivation, attention to hearing aids and spectacles, and prevention or treatment of dehydration.

Management of delirium involves treatment of its causes, supportive care, prevention of complications, and treatment of behavioural symptoms. Adequate lighting and a quiet space is preferred. Prevention of pressure sores and deep vein thrombosis, ensuring night-time sleep and encouraging daytime wakefulness, and close supervision and clear communication to both patient and family are vital. Psychotropic drugs should be used only when symptoms are causing marked distress, threaten safety or interrupt lifesaving treatment. Haloperidol (0.5–1.0 mg 2–3 times daily) has been the traditional agent of choice in these circumstances, but drugs such as olanzapine and risperidone are used increasingly in hospitals, as haloperidol can produce marked extrapyramidal side effects and can affect cardiac conduction.

Delirium can be frightening and bewildering. Families need support and information so that they can understand the changes seen in their relative. Recovered patients often need repeated reassurance and explanation of frightening memories of the delirious episode.

Depression

About 1–2% of older people fulfil criteria for a major depressive disorder and 20% have mild but significant depressive symptoms. Risk factors include female sex, previous depression, pain, physical or sensory handicap, personality disorder, adverse life events, lack of a confiding relationship and poverty. Depression can be triggered by physical conditions (e.g. cancer, stroke and degenerative neurological disorders) or medications (e.g. corticosteroids, L-dopa and methyldopa). Cerebrovascular disease is an important contributing factor in some late-life depressions.

Suicide rates are quite high among older men. Those who commit suicide often live alone and have serious, disabling, painful physical illnesses. Manipulative overdoses are uncommon in old age; any expression of suicidal intent must be taken seriously. For more information on depression, see Chapter 6.

Management

Physical treatments

SSRIs and other modern antidepressants are the drugs of choice for moderate to severe depression. Starting doses are halved for old, frail people, but many require a standard adult dose. Electroconvulsive therapy (ECT) is indicated for marked psychomotor retardation or psychotic symptoms and in those who will not eat or drink and where there is a high risk of suicide.

Bipolar disorder

Mania and bipolar disorder arising after age 50 should be presumed to be organic in origin until proven otherwise. Potential precipitants include antidepressants, ECT, stroke, head injury and medications such as corticosteroids and L-dopa.

Elderly manic patients are overactive and show pressure of speech, flight of ideas, insomnia, disinhibition and poor judgment. Mood is often irritable and in some elderly patients manic and depressive symptoms coexist. Delusions and hallucinations can occur. Patients may be so pressured in thought and speech that they appear to have delirium or dementia.

Usually, admission to hospital is necessary. Atypical antipsychotics are indicated. Mood stabilisers are used acutely and in prophylaxis. Lithium is the treatment of choice, but has a low therapeutic index, and substantial side effects. In frail older people, ideal plasma levels are 0.4–0.6 millimoles/L for treatment and prophylaxis. Sodium valproate is better tolerated, but evidence for its efficacy is less well established.

For more on bipolar disorder, see Chapter 7.

Anxiety disorders

Around 10% of the elderly experience significant symptoms of anxiety. Half of them have always been anxious, but anxiety disorders can arise following physical illness, bereavement, burglary and other adverse events. Panic attacks can simulate angina or myocardial infarction. Many anxious people have comorbid physical disease. Anxiety can lead to avoidance behaviour (e.g. an accidental fall may be followed by reluctance to go out).

Anxious patients need reassurance. Mild episodes often remit spontaneously, but conditions associated with avoidance or panic merit intervention. Anxiolytic medications should be avoided to prevent falls and dependence. Better options include an explanation of the nature of anxiety symptoms, relaxation training and graded exposure to stressors. Cognitive behaviour therapy is effective, but underused due to a lack of trained practitioners. If non-drug treatments fail, a medium-acting benzodiazepine may be warranted for a few days (e.g. oxazepam 7.5 mg twice daily). Some anxious patients, even those in whom depression is not prominent, are helped by the regular prescription of an SSRI antidepressant.

For more on anxiety disorders, see Chapter 8.

Schizophrenia and delusional disorder